Middleweight phenomenon Igor Cavalcanti back Dana White’s “Contender Series” just a few weeks ago, securing him a UFC contract The 98-second destruction of Oscar Ravello in the campaign Meta Apex facility in Las Vegas. Unfortunately, the Brazilian’s debut was put on hold after Cavalcanti tested positive for 19-norandrosterone during a drug test conducted by the Nevada State Athletic Commission (NSAC).
“Igor’s previous use of nandrolone was part of medical treatment following an injury to his right knee that included a medial meniscus tear and cartilage damage,” Cavalcanti manager Lucas Lutkus said. MMA Junkie. “According to the doctor’s medical report, he received three intramuscular injections of 25 mg between February 21 and March 7, 2026 to support muscle recovery and knee stability. At the time, Igor was preparing for a fight in Europe and did not know that he would be competing in the UFC about six months later.”
Before him second period On the “Contender Series,” Cavalcanti scored a first-round TKO victory over Marek Jakimowicz at FNC 31: “Barbir vs. Ilic” on May 30 in Belgrade.
“It is important to emphasize that Igor had previously disclosed his use of nandrolone to the UFC and did not try to hide the treatment,” added Lutkus. “All In Sports Management began representing Igor in June 2026, following the completion of his treatment. Since becoming aware of the situation, we have worked closely with Igor and his medical team to gather the necessary documentation and remain fully committed to transparency and cooperation throughout the process.”
Cavalcanti, who tripped on the first try To clear the “Contender Series” hurdle, the temporary suspension will remain until a future NSAC hearing to evaluate his case. The 29-year-old Brazilian is 14-2 with 11 knockouts and three submissions in his MMA career.
